| |   | | | | By Ed Silverman Sarah Silbiger/Getty Images Drug companies are failing to submit status reports for clinical trials to be conducted after their drugs were approved. Read More | | By Ed Silverman Adobe In many European countries, research and development disclosure policies are regulated by the pharmaceutical industry, not governments. Read More | | By Adam Feuerstein NIAID Nkrarta is among companies developing cell therapies for cancer based on NK cells, the body’s first line of defense against foreign invaders. Read More | | Sponsor content by STAT Events May 3| The journey from lab to patient's bedside Join STAT in Boston to explore the challenges, and the unique opportunities, of the drug development process. We're bringing together speakers from a diverse set of organizations, from Relay Therapeutics to The Progeria Research Foundation, to share their unique perspectives. Get your ticket now to join them. | | By Troy Farah Adobe Parents and doctors now have more tools than ever to help manage symptoms of attention deficit hyperactivity disorder (ADHD) in kids. Read More | |
No comments